Patients with end stage renal disease undergoing dialysis treatment, primary lung disease including moderate to severe chronic obstructive pulmonary disease, musculoskeletal diseases, myocardial infarction or unstable angina within previous 3 months, acute or chronic infection, inflammatory diseases such as sepsis, arthritis or systemic connective tissue disease, symptomatic coronary or peripheral